Pharma Merger

WILMINGTON, Del. - Directors are selling Furiex Pharmaceuticals too cheaply through an unfair process to Forest Laboratories, a $1 billion deal at $95 per share plus "up to $30 per share in a contingent value right," shareholders claim in Chancery Court.